![]() LUPRON DEPOT 3.75 mg or 11.25 mg with iron therapy is used before fibroid surgery to improve anemia due to vaginal bleeding from fibroids for patients in whom 3 months of hormonal suppression is deemed necessary. The total duration of therapy with LUPRON DEPOT 3.75 mg or 11.25 mg plus add-back therapy should not exceed 12 months due to concerns of bone thinning. The thinning of bone and reduce hot flashes associated with use of LUPRON DEPOT Or 11.25 mg is referred to as add-back therapy, and is intended to reduce Use of norethindrone acetate in combination with LUPRON DEPOT 3.75 mg LUPRON DEPOT 3.75 mg or 11.25 mg in combination with norethindrone acetate is used for initial management of the painful symptoms of endometriosisĪnd for management of recurrence of symptoms. Taking LUPRON DEPOT in Combination with Norethindrone Acetate LUPRON DEPOT ® (leuprolide acetate for depot suspension) 3.75 mg or 11.25 mg is used for the management of endometriosis, including pain relief and reduction of endometriotic lesions. Pelvic tenderness and induration were evaluated by pelvic examination. At each study visit, an evaluation was made of dysmenorrhea, NMPP, and dyspareunia by patient interview. ![]() Return of pain was defined to have occurred during the month for which pain levels returned to baseline (prior to treatment) levels or worse. The first day of the study was considered to be 29 days after the final study injection. The primary endometriosis signs and symptoms assessed were dysmenorrhea (painful periods), non-menstrual pelvic pain (NMPP) (pain in the pelvic area before or after periods), dyspareunia (pain during sex), pelvic tenderness (pain during the pelvic examination), and induration (hardening of pelvic tissues). This study grouped patients who received 3.75 mg LUPRON DEPOT during previous trials and assessed recurrence of endometriosis signs and symptoms and safety parameters after discontinuation of treatment. One hundred and twenty-five patients from two 6-month, double-blind, randomized clinical studies entered a 1-year follow-up study. Impaired liver function or liver disease.You should not receive Add-back* plus LUPRON DEPOT if you have or have had any of the following conditions 1: Also do not take LUPRON DEPOT 3.75 mg if you are breastfeeding.Have experienced any type of allergic reaction to LUPRON DEPOT, or similar drugs.You should not receive LUPRON DEPOT if you 1: Contact your doctor immediately if you think you may be pregnant. You should use non-hormonal birth control such as condoms, a diaphragm with contraceptive jelly, or a copper IUD to prevent pregnancy. Even though you may not have a period, unprotected intercourse could result in pregnancy. LUPRON DEPOT is not a method of birth control. You should notify your doctor if you develop any new or worsened symptoms after beginning LUPRON DEPOT treatment. During this time, you may notice an increase in your current symptoms. Your estrogen levels will increase for 1 or 2 weeks after beginning LUPRON DEPOT.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |